An ongoing probe by numerous states widened with a new lawsuit accusing more than two dozen drug makers and several individuals of a widespread conspiracy to fix prices on generic medicines.
The latest lawsuit — the third filed by state attorneys general since late 2016 — accuses the companies of routinely coordinating efforts to fix prices on 80 different creams, gels, lotions, ointments, shampoos, and solutions that are used to treat a pain, allergies, and a variety of skin conditions. The products include hydrocortisone valerate cream, lidocaine ointment, and acetazolamide tablets.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
